The director, In effort with various operational counterparts within the company and with external suppliers/vendors, Will ensure therapeutic strategy development and the clinical and operational implementation of company sponsored studies, researcher initiated studies and post marketing risk management research programs, in in sourced, Outsourced or matrixed corporations. whomever will focus on Phase II Phase IV studies, Post marketing risk management research programs and IIS trials to ensure strategic level plans are executed in a timely and compliant fashion for satisfaction of Medical Affairs' research goals. Manage and be the reason for budgets for multiple therapeutic areas across the portfolio.

from the